Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pharvaris
Pharvaris
Pharvaris' oral hereditary angioedema med slashes attacks in turnaround post-FDA hold
Fierce Biotech
Wed, 12/6/23 - 10:34 am
Pharvaris
HAE
clinical trials
deucrictibant
Pharvaris studies of rare disease drug put on hold by FDA
BioPharma Dive
Mon, 08/22/22 - 08:12 pm
Pharvaris
FDA
hereditary angiodema
HAE
PHA121
IPO tracker: 2021 gets started with a flurry of new offerings
Endpoints
Mon, 01/25/21 - 10:43 am
IPOs
Sana Biotechnology
Sensei Biotherapeutics
Bolt Biotherapeutics
Immunocore
Terns Pharmaceuticals
Pharvaris
Vor Biopharma
Adagene
NexImmune
Biophytis
Gracell Biotechnologies
Cullinan Oncology
Pharvaris lands another $80M as it looks to tackle Takeda and CSL with an oral approach for HAE
Endpoints
Wed, 11/18/20 - 11:07 pm
Pharvaris
HAE
Takeda
CSL
After BioCryst fizzle, a new oral HAE player emerges
Endpoints
Tue, 09/10/19 - 11:10 am
HAE
Pharvaris
clinical trials
PHAp121
Biocryst